Cloudbreak Pharma Inc. (HKG:2592)

Cloudbreak Pharma Statistics

Total Valuation

HKG:2592 has a market cap or net worth of HKD 1.89 billion. The enterprise value is 4.50 billion.

Market Cap	1.89B
Enterprise Value	4.50B

Important Dates

The next estimated earnings date is Tuesday, June 23, 2026.

Earnings Date	Jun 23, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:2592 has 838.89 million shares outstanding. The number of shares has increased by 3.66% in one year.

Current Share Class	838.89M
Shares Outstanding	838.89M
Shares Change (YoY)	+3.66%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	44.13%
Owned by Institutions (%)	n/a
Float	276.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	23.48
PB Ratio	-0.73
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-13.71
EV / Sales	55.99
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-21.82

Financial Position

The company has a current ratio of 0.06

Current Ratio	0.06
Quick Ratio	0.04
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-13.25
Interest Coverage	-1,716.96

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	13.01%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.34M
Profits Per Employee	-5.47M
Employee Count	60
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, HKG:2592 has paid 7.26 million in taxes.

Income Tax	7.26M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	4.25
200-Day Moving Average	n/a
Relative Strength Index (RSI)	29.32
Average Volume (20 Days)	1,017,150

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2592 had revenue of HKD 80.40 million and -328.39 million in losses. Loss per share was -1.32.

Revenue	80.40M
Gross Profit	80.40M
Operating Income	-336.95M
Pretax Income	-321.13M
Net Income	-328.39M
EBITDA	-332.37M
EBIT	-336.95M
Loss Per Share	-1.32

Balance Sheet

The company has 118.46 million in cash and 2.73 billion in debt, with a net cash position of -2.61 billion or -3.12 per share.

Cash & Cash Equivalents	118.46M
Total Debt	2.73B
Net Cash	-2.61B
Net Cash Per Share	-3.12
Equity (Book Value)	-2.59B
Book Value Per Share	-5.45
Working Capital	-2.62B

Cash Flow

In the last 12 months, operating cash flow was -204.94 million and capital expenditures -1.36 million, giving a free cash flow of -206.30 million.

Operating Cash Flow	-204.94M
Capital Expenditures	-1.36M
Free Cash Flow	-206.30M
FCF Per Share	-0.25

Margins

Gross Margin	100.00%
Operating Margin	-419.10%
Pretax Margin	-399.41%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HKG:2592 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.66%
Shareholder Yield	-3.66%
Earnings Yield	-17.40%
FCF Yield	-10.93%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2592 has an Altman Z-Score of -38.61 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-38.61
Piotroski F-Score	1